Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

GLAND PHARMA LTD.

NSE : GLANDBSE : 543245ISIN CODE : INE068V01023Industry : Pharmaceuticals & DrugsHouse : Private

BSE1919.3550.75 (+2.72 %)

PREV CLOSE ( ) 1868.60

OPEN PRICE ( ) 1849.25

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 3170

TODAY'S LOW / HIGH ( )1849.25 1929.00

52 WK LOW / HIGH ( )1200 2130

NSE1921.0042.9 (+2.28 %)

PREV CLOSE( ) 1878.10

OPEN PRICE ( ) 1878.00

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 1921.00 (119)

VOLUME 431248

TODAY'S LOW / HIGH( ) 1871.50 1930.00

52 WK LOW / HIGH ( )1277.8 2131

Select year

(Rs.in Million)

Particulars

Mar 2025

Mar 2024

Mar 2023

Mar 2022

Mar 2021

Profit Before Tax

10626.58

11325.42

10545.82

16185.52

13348.10

Adjustment

2119.38

2236.03

381.92

-282.66

173.03

Changes In working Capital

-60.63

-531.99

-4179.41

-3930.08

-4357.59

Cash Flow after changes in Working Capital

12685.33

13029.46

6748.33

11972.78

9163.54

Cash Flow from Operating Activities

9147.30

9967.97

3639.68

7907.69

6049.29

Cash Flow from Investing Activities

17047.36

-17569.11

12081.88

-10026.21

-15240.00

Cash Flow from Financing Activities

-4334.76

-7994.16

149.19

348.98

12384.60

Net Cash Inflow / Outflow

21859.90

-15595.30

15870.75

-1769.54

3193.89

Opening Cash & Cash Equivalents

3570.88

19088.95

3188.20

4924.63

1694.97

Cash & Cash Equivalent on Amalgamation / Take over / Merger

Cash & Cash Equivalent of Subsidiaries under liquidations

Translation adjustment on reserves / op cash balalces frgn subsidiaries

Effect of Foreign Exchange Fluctuations

131.31

77.23

30.00

33.11

35.77

Closing Cash & Cash Equivalent

25562.09

3570.88

19088.95

3188.20

4924.63